1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow TheraOp: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC standard Radiotherapy, Chemotherapy, Immunotherapy - Stage III Non-small Cell Lung Cancer, Locally Advanced | Phase 2 | Recruiting | TheraOp | 110 | 2024-07-01 | 2025-12-17 |
| MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab Cetuximab, FOLFIRI - Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 2 | Completed | TheraOp | 6 | 2020-12-29 | 2025-06-08 |
Carcinoma, Non-Small-Cell Lung (1) · Colonic Neoplasms (1) · Rectal Neoplasms (1)
Cetuximab (1) · Drug Therapy (1) · IFL protocol (1) · Immunotherapy (1)
Germany (2) · Switzerland (1)
Stefan Rieken, Prof. (1) · Ursula Nestle, Prof. (1)